Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Carrington
WARNING LETTER
•Carrington•August 1, 2014

Carrington – FDA Warning Letter, Aug 1, 2014

Record Details

The FDA issued a Warning Letter to Carrington Farms in April/August 2014 after reviewing their Coconut Oil product label and website. The FDA determined that the product is promoted for conditions that classify it as an unapproved new drug under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act). Examples of therapeutic claims include treating infections (salmonella, ringworm, candidiasis, gastroenteritis), exhibiting anti-viral/microbial/fungal properties, easing acid reflux, lowering hemorrhoid incidence, soothing earaches, reducing inflammation, and preventing osteoporosis. Since the product is not generally recognized as safe and effective for these uses, it is an unapproved new drug under section 201(p) and its introduction into interstate commerce violates section 301(d). Furthermore, the product is misbranded under section 502(f)(1) because it lacks adequate directions for layperson use.

Even if not an unapproved drug, the product is a misbranded food under section 403(r)(1) due to unauthorized nutrient content claims. Claims like "Healthy Foods," "The healthiest oil on earth," and "Perfect for healthy...cooking" are used despite the product exceeding saturated fat limits and lacking sufficient vitamins/minerals to qualify as "healthy" per 21 CFR 101.65(d). The claim "low in calories" is

Company
Carrington
Inspection date
August 1, 2014
Product type
Food
Office
Center for Food Safety and Applied Nutrition
Person
  • William A. Correll (Director)
View Company Profile

ID · 23e2fdc9-d625-4c9c-bf77-6ed36d6e4e68

Violation Codes10
21 U.S.C. 321(g)(1)(B)21 U.S.C. 343(r)(1)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 352(f)(1)21 U.S.C. 343(r)(1)(A)21 CFR 101.65(d)21 CFR 101.62(c)(2)21 CFR 101.60(b)(2)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Carrington
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.